Yes Filsuvez® is available on prescription now for patients aged 6 months+ with Junctional and Dystrophic EB in England, Wales, and Northern Ireland. Filsuvez® has also been approved by the Scottish Medicines Consortium and we expect it to be available on prescription through NHS Scotland following agreement between Chiesi, the pharmaceutical company who developed the drug, and the Scottish Government on the data collection requirements, this is expected by September 2024.